Lung cancer screening (LCS) with low-dose CT (LDCT) is an effective tool for reducing lung cancer mortality among high-risk individuals, yet utilization of such screening remains low. What can be done to remedy this situation?

Catch up on all things fraud and ethics around the healthcare industry with HealthExec’s weekly watchdog report.

Digital breast tomosynthesis (DBT) leads to fewer false-positive (FP) recalls than full-field digital mammography (FFDM), according to new findings published in Academic Radiology. The patient’s age and the availability of prior mammograms were also important factors.

A bigger bonus size for physicians is associated with higher-value medicine, according to a recent study published in JAMA Open Network.

While many men with low-risk prostate cancer have been known to undergo immediate surgery or radiation treatment, a new study in JAMA found that more men are choosing active surveillance. 

Mammography and advances in breast cancer treatment have saved the lives of hundreds of thousands of women in the United States over the last three decades, according to new research published by Cancer.

Here are some of the top stories from around the web covering healthcare fraud and ethics issues.

Anthem, the second largest health insurer in the nation, is facing a class action lawsuit for allegedly misleading thousands of Georgia consumers during the 2018 open enrollment period.